Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6806
Rank
โ‚ฌ0.52 B
Marketcap
26,41ย โ‚ฌ
Share price
-0.17%
Change (1 day)
-12.60%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ44.28 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are โ‚ฌ44.28 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ40.61 M14.91%
2023-12-31โ‚ฌ35.34 M